Shares in US pharma giant Merck & Co (NYSE: MRK) were nearly 2% higher in early trading Monday.

Shares of Avidity Biosciences (Nasdaq: RNA) were up almost 5% at $38.00 pre-market today, as it announced the accelerated ...

George Medicines, a late-stage UK-based biopharmaceutical company focused on addressing unmet needs in cardiometabolic ...

UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease ...

South Korea’s biosimilar drug developer Samsung Bioepis has announced that the company has entered into a license, ...

Swiss skincare specialist Galderma has announced two-year data from a new interim analysis of a long-term extension study ...

As Denmark presses ahead with a major health reform, a coalition of rare disease advocates and clinicians is urging the ...

French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...

The Russian pharmaceutical market, valued at around $41 billion, continues to be a magnet for Indian pharmaceutical companies ...

US biotech PureTech Health (Nasdaq: PRTC) is positioning its lead candidate LYT-100 as a potential disruptor in the treatment of idiopathic pulmonary fibrosis (IPF), a rare lung condition long ...

The European Council of Minister last week said it is ready to begin negotiations with the European Parliament, having agreed ...

Knight will have the exclusive rights to distribute, promote, market and sell the products in Canada, and said it will begin ...